SG Americas Securities LLC Makes New $252,000 Investment in Clover Health Investments, Corp. (NASDAQ:CLOV)

SG Americas Securities LLC purchased a new position in shares of Clover Health Investments, Corp. (NASDAQ:CLOV) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 89,236 shares of the company’s stock, valued at approximately $252,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CLOV. Jaffetilchin Investment Partners LLC grew its stake in shares of Clover Health Investments by 30.2% in the first quarter. Jaffetilchin Investment Partners LLC now owns 49,741 shares of the company’s stock valued at $39,000 after buying an additional 11,550 shares in the last quarter. Vanguard Personalized Indexing Management LLC grew its stake in shares of Clover Health Investments by 54.4% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 34,372 shares of the company’s stock valued at $42,000 after buying an additional 12,104 shares in the last quarter. Viewpoint Capital Management LLC boosted its holdings in Clover Health Investments by 96.8% in the second quarter. Viewpoint Capital Management LLC now owns 30,500 shares of the company’s stock valued at $38,000 after purchasing an additional 15,000 shares during the last quarter. AQR Capital Management LLC boosted its holdings in Clover Health Investments by 4.6% in the second quarter. AQR Capital Management LLC now owns 729,706 shares of the company’s stock valued at $898,000 after purchasing an additional 32,288 shares during the last quarter. Finally, Marshall Wace LLP purchased a new position in Clover Health Investments in the second quarter valued at about $55,000. 19.77% of the stock is currently owned by institutional investors and hedge funds.

Clover Health Investments Stock Performance

Shares of CLOV opened at $4.06 on Tuesday. The company has a market capitalization of $2.02 billion, a P/E ratio of -11.94 and a beta of 2.13. Clover Health Investments, Corp. has a one year low of $0.61 and a one year high of $4.71. The stock has a 50-day moving average price of $3.18 and a 200 day moving average price of $1.86.

Clover Health Investments (NASDAQ:CLOV) last issued its quarterly earnings results on Monday, August 5th. The company reported $0.01 EPS for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.05. Clover Health Investments had a negative return on equity of 36.55% and a negative net margin of 7.30%. The firm had revenue of $356.26 million during the quarter, compared to the consensus estimate of $338.70 million. During the same quarter in the prior year, the business posted ($0.06) earnings per share. As a group, equities research analysts forecast that Clover Health Investments, Corp. will post -0.13 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, UBS Group initiated coverage on Clover Health Investments in a report on Monday, October 7th. They issued a “neutral” rating and a $4.00 price target for the company.

Clover Health Investments Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.